Evidence map›Paper›PMID 41198753›Full record

ArticleScientific reports2025

Antibiofilm activity of cationic carbosilane BD132 dendron and its synergistic effect with amphotericin B against Candida spp.

Natalia Gómez-Casanova, José Luis Copa-Patiño, Rafael Gómez, Javier Sánchez-Nieves, Irene Heredero-Bermejo

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natalia Gómez-CasanovaUniversidad de Alcalá, Department of Biomedicine and Biotechnology, Faculty of Pharmacy, Alcalá de Henares, 28871, Spain.
José Luis Copa-PatiñoUniversidad de Alcalá, Department of Biomedicine and Biotechnology, Faculty of Pharmacy, Alcalá de Henares, 28871, Spain.
Rafael GómezUniversidad de Alcalá, Department of Organic Chemistry and Inorganic Chemistry, Institute of Chemical Research "Andrés M. del Río" (IQAR), Alcalá de Henares, Spain.
Javier Sánchez-NievesUniversidad de Alcalá, Department of Organic Chemistry and Inorganic Chemistry, Institute of Chemical Research "Andrés M. del Río" (IQAR), Alcalá de Henares, Spain.
Irene Heredero-BermejoUniversidad de Alcalá, Department of Biomedicine and Biotechnology, Faculty of Pharmacy, Alcalá de Henares, 28871, Spain. irene.heredero@uah.es.

Funding

Comunidad de Madrid CM/JIN/2021-029Comunidad de Madrid-UAH EPU-INV/2020/014Ministerio de Ciencia e Innovación PID2020-112924RB-I00Ministerio de Ciencia e Innovación PID2020 113274RA I00/AEI/10.13039/501100011033
6 · The paper itself

Abstract

The BD132 is a cationic carbosilane dendron containing peripheral ammonium groups, which impairs antimicrobial properties, and the chaperone 4-phenylbutyrate, with anti-inflammatory and antibacterial properties. Its in vitro activity was evaluated against biofilm formation and against established biofilms in Candida albicans and Nakaseomyces glabratus (former named Candida glabrata). In addition, the BD132 dendron was used in combination with amphotericin B against both species. Its cytotoxicity was evaluated using HeLa cells. Our data showed that BD132 dendron was an excellent compound that prevented biofilm formation. The Minimum Biofilm Inhibitory Concentration was 16 mg/L for N. glabratus and 32 mg/L for C. albicans, both concentrations were not cytotoxic. Furthermore, in the studies against established biofilms, the dendron was effective eradicating them. Experiments showed that the combination of the dendron with amphotericin B improved the activity of both by reducing the effective concentration of both compounds required to obtain the same results as when used individually. Therefore, the BD132 dendron is a very interesting compound that exhibits low cytotoxicity at active concentrations that prevent the formation of biofilms of these microorganisms. In addition, these results suggest that the BD132 dendron may have great benefits in the development of antifungal agents.

Indexed as

Amphotericin BAntifungal AgentsBiofilmsCandidaDendrimersSilanesCandida albicansCationsDrug SynergismHeLa CellsHumansMicrobial Sensitivity TestsAmphotericin BAntifungal AgentscarbosilaneCationsDendrimersSilanesAmphotericinBiocide synergyBiofilmCandida albicansDendritic systemsNakaseomyces glabratus

Identifiers

PMID41198753
PMCPMC12592490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.